Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: A retrospective single-centre study. | Haemophilia | 2022 | 35122661 | PubTator, text mining | PubMed |
| Inhibition of caspase-1-mediated inflammasome activation reduced blood coagulation in cerebrospinal fluid after subarachnoid haemorrhage. | EBioMedicine | 2022 | 35101655 | PubTator, text mining | PubMed |
| Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo. | J Transl Med | 2022 | 35101062 | PubTator, text mining | PubMed |
| Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains. | Blood Adv | 2022 | 35086137 | PubTator, text mining | PubMed |
| Color appearance shifts depending on surface roughness, illuminants, and physical colors. | Sci Rep | 2022 | 35079070 | PubTator, text mining | PubMed |
| Intraoperative thromboelastography-guided transfusion in a patient with factor XI deficiency: A case report. | World J Clin Cases | 2022 | 35071523 | PubTator, text mining | PubMed |
| Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity. | Pharmaceutics | 2022 | 35057027 | PubTator, text mining | PubMed |
| Reference values of coagulation assays performed for thrombophilia screening after a first venous thrombosis and their intra-patient associations. | Thromb Res | 2022 | 35042062 | PubTator, text mining | PubMed |
| Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN study. | J Thromb Haemost | 2022 | 35038781 | PubTator, text mining | PubMed |
| Neutralizing monoclonal antibodies against highly pathogenic coronaviruses. | Curr Opin Virol | 2022 | 35038651 | PubTator, text mining | PubMed |
| Aptamer-based factor IXa inhibition preserves hemostasis and prevents thrombosis in a piglet model of ECMO. | Mol Ther Nucleic Acids | 2022 | 35036063 | PubTator, text mining | PubMed |
| The role of phosphatidylserine on the membrane in immunity and blood coagulation. | Biomark Res | 2022 | 35033201 | PubTator, text mining | PubMed |
| Neuropsychiatric syndrome with myoclonus after SARS-CoV-2 infection in a paediatric patient. | Clin Neurol Neurosurg | 2022 | 35030418 | PubTator, text mining | PubMed |
| Stability of coagulation parameters in plasma samples at room temperature after one freeze/thaw cycle. | Int J Lab Hematol | 2022 | 35029031 | PubTator, text mining | PubMed |
| Role of von Willebrand factor in venous thromboembolic disease. | JVS Vasc Sci | 2022 | 35028601 | PubTator, text mining | PubMed |
| DNase 1 Protects From Increased Thrombin Generation and Venous Thrombosis During Aging: Cross-Sectional Study in Mice and Humans. | J Am Heart Assoc | 2022 | 35023342 | PubTator, text mining | PubMed |
| Factor XI as a target for preventing venous thromboembolism. | J Thromb Haemost | 2022 | 35023278 | PubTator, text mining | PubMed |
| Coagulation profile of human COVID-19 convalescent plasma. | Sci Rep | 2022 | 35022488 | PubTator, text mining | PubMed |
| The antithrombosis effect of dehydroandrographolide succinate: in vitro and in vivo studies. | Pharm Biol | 2022 | 35014931 | PubTator, text mining | PubMed |
| Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study. | Br J Clin Pharmacol | 2022 | 35014061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=42